Editoriais

It’s time to review last year’s figures, read on about our good chemistry in 2023!

We had the pleasure to host the VIII SEQT Summer School “Medicinal Chemistry and Chemical Biology in Drug Discovery: The Pharma Perspective”.

Read on about our good chemistry in 2022! All our numbers are presented as part of our commitment to transparency.

You need a molecule (big or small) to make a drug and, ultimately, to make a molecule, you will need a synthetic chemist.

The 2022 Chemistry Nobel Prize has been awarded to Carolyn R. Bertozzi, Morten Meldal, and K. Barry Sharpless “for the development of click chemistry and bioorthogonal chemistry”.

Our annual exercise of transparency. Read on about our good chemistry and how we performed in 2021.

The 2021 Chemistry Nobel Prize has been awarded to Benjamin List and David MacMillan “for the development of asymmetric organocatalysis”.

One more year of great productivity for GalChimia! Click here to see the achievements of our teams of chemists.

Here is our tribute to Emmanuelle Charpentier and Jennifer Doudna for their pioneering work in gene editing and the preceding discoveries that made possible the development of CRISPR technology

In GalChimia, as part of the MedChem community, we feel this could be a good time to reflect and share some thoughts about the COVID-19 situation.

Gaich et al. have recently reported the total synthesis of an extremely complicated molecule, canataxpropellane. We thus wonder, have we reached the limits of synthetic complexity?

One more year of great productivity for GalChimia! Click here to see the achievements of our teams of chemists.

It’s time to talk about the chemical elements that fill the periodic table. Have you ever wondered why we have so many (or so few) elements? Keep reading!

The Rule of Five has had a remarkable effect on drug discovery strategies; twenty years on, the history of this set of rules can be described as both influential and controversial.

The Chemistry Nobel Prize has been awarded to John B. Goodenough, M. Stanley Whittingham, and Akira Yoshino for the development of lithium-ion batteries.

The European Union becomes the first governing body in the world to recognize plant biostimulants as a distinct category of agricultural inputs.

This document includes the most relevant data on the evolution of the sector, as compiled by the Spanish Statistical Office and further analyzed by Asebio.

The chemical elements can be arranged in many different ways, and here we show you some of our favorite designs.

Bremelanotide (commercialized as Vyleesi) has recently been approved by the FDA for the treatment of low sexual desire in women.

2019 is the International Year of the Periodic Table, an initiative by the IUPAC with support from the UNESCO.

Would you crash your own presentation? We give you 10 techniques and other small tricks to follow to make an attractive presentation.

GalChimia customers come from several industries, but the majority can be classified into two categories: agrochemical and pharmaceutical. What are the…

Our immune system does a remarkable job of defending us against diseases. We can also consider that it has the greatest…

“This generic is an exact copy of your formal medicine.” We have all heard this assurance from our pharmacists, but why…

The “One Health” approach emerged following the unprecedented global response to the highly pathogenic avian influenza in 2007, but the philosophy…

Looking for new customers in France, Belgium, United Kingdom, and other European countries, I realized that the number of pharmaceutical companies…

Copper-Catalyzed Selective Arylations of Benzoxazoles with Aryl Iodides Still trying to decide if this is a joke or not. Any help…

Being French, living in Spain and working in English I read different news items from different countries in several languages. Recently,…

One of my favourites blogs, which I have mentioned in previous posts, is In the Pipeline, written by Derek Lowe. He…

Everything started with a headline: “Most cancers are caused by bad luck – not bad judgement, says study” (Independent), and another:…

For the first time in 10 years there is no pharmaceutical company among the three biggest R&D spenders! According to the…

Well, it is the first anti-obesity drug approved by the FDA in 13 years (last one was Roche’s Orlistat, marketed as Xenical…

During the last CPhI in Frankfurt we officially presented our joint venture with Applus+ LGAI, christening it GalChimiApplus. This collaboration will…

The review selected for this issue is in fact what the J. Med. Chem. calls a ‘Perspective’ paper. To summarize, it…

Are medicinal chemists simple-minded? Have they forgotten how to synthesize molecules? Have they become lazy? If you think the answers to…

Well, it has been a long, long time. Issue 18 of the newsletter was published on April 1st, so you readers…

IT’S THE END OF THE WORLD AS WE KNOW IT Probably most of you are not familiar with this song by…

Last Year Figures If you have lived through the 80s you will probably remember this word. Another year is behind us…

Green Chemistry Are you familiar with the twelve points of Green Chemistry? No? Well, maybe it is because you are a…

In the last years there has been an increasing number of chiral New Chemical Entities (NCEs) entering the pipeline of the…

When you spend some time working in the field of Organic Synthesis you understand that Chemistry, as many other things, it…

We are proud to announce the launching of our new website. The site has been completely built up with a brand…

Interesting Times An ancient chinese curse says that “May you live in interesting times”. This crisis is an interesting time indeed,…

In the next months, we will publish a couple of papers on our research on organometallic couplings. Even if they are…

In the last six months, the pharmaceutical industry has seen three acquisitions: Pfizer eats Wyeth, Merck eats Schering-Plough, and Roche eats…

In the last months, some of our clients have expressed their interest (though maybe concern would be more appropriate) about where…

You have on your screen the seventh number of our newsletter. When we started with this project, our intention was to…

Letter to Santa Claus Or to the Three Wise Men, depending on your preferences. Anyway, Christmas is coming, we have been…

You have on your screen the third number of our newsletter. When we started this project, by the end of 2007,…

This is the first issue of our newsletter. Yes, another one. There are other newsletters centered in industry drivers, news, product…

Welcome to our newsletter, Doing Chemistry. Since this is the first issue, we believe necessary to establish the “broad and scope”…